Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.3772
H.R.3772: Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced July 16, 2019
- Latest Major Action July 17, 2019
- See the three similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
24 (16 Democrats, 8 Republicans)
Bill Version
- Introduced in House - July 16, 2019
Bill Summary
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2020 and as adjusted based on a specified fee schedule factor in each year thereafter.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| July 17, 2019 |
Referred to the Subcommittee on Health.
|
| July 16, 2019 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
| July 16, 2019 |
Introduced in the House by Scott Peters (D-Calif.) |